Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Kennedy

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cancers|March 25, 2022
Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple MyelomaThomas A Burley, Emma Kennedy, Georgia Broad, et al.
Respirology (Carlton, Vic.)|March 2, 2023
Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New ZealandAnne B Chang, Scott C Bell, Catherine A Byrnes, et al.
Elife|April 19, 2022
Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic targetUjjwal Neogi, Nazif Elaldi, Sofia Appelberg, et al.
BMC Health Services Research|April 10, 2024
Transitioning to home and beyond following stroke: a prospective cohort study of outcomes and needsGeraldine O'Callaghan, Martin Fahy, Sigrid O'Meara, et al.
Antibody Therapeutics|May 18, 2026
A hyperimmune ovine antibody-based therapeutic candidate against Crimean-Congo haemorrhagic fever virus targeted to the Gn and Gc glycoproteins: high antibody levels with neutralization activity but lack of protective efficacy in a mouse modelEmma Kennedy, Stephen Findlay-Wilson, Sarah Webster, et al.
Cancers|January 11, 2025
A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug ResistanceEleni E Ladikou, Kim Sharp, Fabio A Simoes, et al.
American Journal of Human Genetics|December 20, 2025
Racial and socioeconomic disparities in genetic evaluation and testing in the adult patient populationJessica I Gold, Yehuda Elkaim, Nina B Gold, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Practice-Based Insights into Adult Genetics: High Diagnostic Yield, Demographic Determinants, and Patterns of Test Utilization in Over 7,000 PatientsJessica I Gold, Yehuda Elkaim, Stephanie Asher, et al.
The Journal of General Virology|October 6, 2025
Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccineMartina Pfranger, Nina Krause, Benedikt Asbach, et al.
Virus Research|May 30, 2024
Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse modelSarah Kempster, Mark Hassall, Victoria Graham, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancers|March 25, 2022
Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple MyelomaThomas A Burley, Emma Kennedy, Georgia Broad, et al.
Respirology (Carlton, Vic.)|March 2, 2023
Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New ZealandAnne B Chang, Scott C Bell, Catherine A Byrnes, et al.
Elife|April 19, 2022
Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic targetUjjwal Neogi, Nazif Elaldi, Sofia Appelberg, et al.
BMC Health Services Research|April 10, 2024
Transitioning to home and beyond following stroke: a prospective cohort study of outcomes and needsGeraldine O'Callaghan, Martin Fahy, Sigrid O'Meara, et al.
Antibody Therapeutics|May 18, 2026
A hyperimmune ovine antibody-based therapeutic candidate against Crimean-Congo haemorrhagic fever virus targeted to the Gn and Gc glycoproteins: high antibody levels with neutralization activity but lack of protective efficacy in a mouse modelEmma Kennedy, Stephen Findlay-Wilson, Sarah Webster, et al.
Cancers|January 11, 2025
A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug ResistanceEleni E Ladikou, Kim Sharp, Fabio A Simoes, et al.
American Journal of Human Genetics|December 20, 2025
Racial and socioeconomic disparities in genetic evaluation and testing in the adult patient populationJessica I Gold, Yehuda Elkaim, Nina B Gold, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Practice-Based Insights into Adult Genetics: High Diagnostic Yield, Demographic Determinants, and Patterns of Test Utilization in Over 7,000 PatientsJessica I Gold, Yehuda Elkaim, Stephanie Asher, et al.
The Journal of General Virology|October 6, 2025
Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccineMartina Pfranger, Nina Krause, Benedikt Asbach, et al.
Virus Research|May 30, 2024
Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse modelSarah Kempster, Mark Hassall, Victoria Graham, et al.
Pageof 5